Configuration

TREC 2020 PM run bm25 (ASCFDA)

Submitted run as evaluated by the track.

Overview

Submitted run as evaluated by the track.

Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.

Evaluations and results

1 evaluation · 1 result. Different protocols are not a single leaderboard.

Filter evaluations

Tested model or methodProtocolDatasetEvaluation setupMetricEvidence origin

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configuration	Protocol and dataset	Finding	Evidence and details
Configuration: TREC 2020 PM run bm25 (ASCFDA)	Protocol: TREC 2020 PM Phase 1: topical relevance of retrieved MEDLINE abstracts Dataset: TREC 2020 Precision Medicine: 40 cancer-gene-treatment topics over a 2019 MEDLINE baseline snapshot	0.535 precision-at-10 unitless · higher Uncertainty: Not reported by the source Coverage: Not reported scored / Not reported eligible	Independent external evaluation · Source checked Methods, coverage and source bm25 (ASCFDA), TREC 2020 PM Phase 1 egfrnsclc-20261009-protocol-trec2020-pm-phase1-relevance Aggregation: Not reported Overview of the TREC 2020 Precision Medicine Track; NIST TREC Browser, Precision Medicine 2020 runs page · Overview Table 5 (PDF page 9), block 'P@10', row 4: team 'ASCFDA', run 'bm25'

Source checking is not independent reproduction. Release 2026-10-09-ba02f2f4a36e.

Use this model

How it works, versions and access

Strengths, limitations and unresolved questions

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

0 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-09-ba02f2f4a36e
Property and statement	Original source and location	Review and provenance

No evidence rows match these filters. Choose another scope or clear the search.

All evidence (JSONL) (gzip)How to read the evidence

Sources and history

Release 2026-10-09-ba02f2f4a36e · Record review: source checked

2 source records and release history

Overview of the TREC 2020 Precision Medicine Track · Original source · Proceedings of the Twenty-Ninth Text REtrieval Conference (TREC 2020), NIST Special Publication 1266; 10-page PDF
NIST TREC Browser, Precision Medicine 2020 runs page · Original source · usnistgov/trec-browser commit 75ec9339eac60126b1045e5858a5ac874ea54a51

Download this release (gzip)

Technical metadata and extraction receipts

Stable ID: egfrnsclc-20261009-config-trec2020-pm-bm25

areas: dna-genomes
contexts: clinical_research
method types: conventional_pipeline
reported name: bm25
foundation model eligible: false
source locator: Overview Tables 5-6; TREC browser runs page, run bm25
missing metadata: version: reason: inapplicable; note: A submitted run is a fixed artifact; its MD5 is recorded where listed
parameters: Run type: automatic. Run description as submitted: Abstracts are retrieved using Anserini's BM25 with default parameters.
model identity note: Run provenance: run_id bm25; run_file_md5 783f0d3972885a80ede4aa9fdc1a6237; listed_in TREC browser runs page

Related records

configuration of: TREC 2020 PM system of team ASCFDA
system: bm25 (ASCFDA), TREC 2020 PM Phase 1

Suggest a correction